North America holds a significant share of the adiponectin testing market, driven by increasing awareness of metabolic health, well-established healthcare systems, and growing use of advanced diagnostic technologies. The region also benefits from continuous research activities, expanding preventive healthcare initiatives, and the presence of leading diagnostic companies, supporting steady...